Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.

Chua JV, Price A, Sharaf S, Camacho Ortega S, Bernal PJ, Butler L, Koudjra AR, Joshi S, Hardy CSC, Currier JR, Waickman AT, Cairo C, Friberg H, Edelman R, Lyke KE

Open source

DOI: 10.1016/j.lanmic.2026.101542
Published: 2026 Oct 29
Container: The Lancet. Microbe
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2026.101542,
  title = {Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.},
  author = {Chua JV and Price A and Sharaf S and Camacho Ortega S and Bernal PJ and Butler L and Koudjra AR and Joshi S and Hardy CSC and Currier JR and Waickman AT and Cairo C and Friberg H and Edelman R and Lyke KE},
  year = {2026},
  journal = {The Lancet. Microbe},
  doi = {10.1016/j.lanmic.2026.101542},
  url = {https://doi.org/10.1016/j.lanmic.2026.101542}
}

RIS

TY  - JOUR
TI  - Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.
AU  - Chua JV
AU  - Price A
AU  - Sharaf S
AU  - Camacho Ortega S
AU  - Bernal PJ
AU  - Butler L
AU  - Koudjra AR
AU  - Joshi S
AU  - Hardy CSC
AU  - Currier JR
AU  - Waickman AT
AU  - Cairo C
AU  - Friberg H
AU  - Edelman R
AU  - Lyke KE
PY  - 2026
JO  - The Lancet. Microbe
DO  - 10.1016/j.lanmic.2026.101542
UR  - https://doi.org/10.1016/j.lanmic.2026.101542
ER  -

APA

JV, C., A, P., S, S., S, C. O., PJ, B., L, B., AR, K., S, J., CSC, H., JR, C., AT, W., C, C., H, F., R, E., & KE, L. (2026). Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.. The Lancet. Microbe. https://doi.org/10.1016/j.lanmic.2026.101542

Source records

pubmed · retrieved 2026-11-10T21:08:07.046Z